These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 11249822

  • 1. Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones.
    Sanders CC.
    Clin Infect Dis; 2001 Mar 15; 32 Suppl 1():S1-8. PubMed ID: 11249822
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.
    Ruiz J.
    J Antimicrob Chemother; 2003 May 15; 51(5):1109-17. PubMed ID: 12697644
    [Abstract] [Full Text] [Related]

  • 3. Quinolone resistance in Staphylococci: activities of new nonfluorinated quinolones against molecular targets in whole cells and clinical isolates.
    Roychoudhury S, Catrenich CE, McIntosh EJ, McKeever HD, Makin KM, Koenigs PM, Ledoussal B.
    Antimicrob Agents Chemother; 2001 Apr 15; 45(4):1115-20. PubMed ID: 11257024
    [Abstract] [Full Text] [Related]

  • 4. [Mechanisms of bacterial resistance to quinolones].
    Taléns-Visconti R, Garrigues TM, Cantón E.
    Rev Esp Quimioter; 2002 Mar 15; 15(1):25-31. PubMed ID: 12582434
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms of resistance to quinolones.
    Jacoby GA.
    Clin Infect Dis; 2005 Jul 15; 41 Suppl 2():S120-6. PubMed ID: 15942878
    [Abstract] [Full Text] [Related]

  • 6. Quinolone resistance mechanisms in pneumococci.
    Eliopoulos GM.
    Clin Infect Dis; 2004 May 15; 38 Suppl 4():S350-6. PubMed ID: 15127369
    [Abstract] [Full Text] [Related]

  • 7. Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.
    McIver C, Hogan T, White P, Tapsall J.
    Pathology; 2004 Apr 15; 36(2):166-9. PubMed ID: 15203753
    [Abstract] [Full Text] [Related]

  • 8. Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance.
    Schmitz FJ, Higgins PG, Mayer S, Fluit AC, Dalhoff A.
    Eur J Clin Microbiol Infect Dis; 2002 Sep 15; 21(9):647-59. PubMed ID: 12373497
    [Abstract] [Full Text] [Related]

  • 9. Quinolones in 2005: an update.
    Van Bambeke F, Michot JM, Van Eldere J, Tulkens PM.
    Clin Microbiol Infect; 2005 Apr 15; 11(4):256-80. PubMed ID: 15760423
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms of action of antimicrobials: focus on fluoroquinolones.
    Hooper DC.
    Clin Infect Dis; 2001 Mar 15; 32 Suppl 1():S9-S15. PubMed ID: 11249823
    [Abstract] [Full Text] [Related]

  • 11. Resistance in gram-negative bacteria: enterobacteriaceae.
    Paterson DL.
    Am J Med; 2006 Jun 15; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
    [Abstract] [Full Text] [Related]

  • 12. [Quinolones and Streptococcus pneumoniae. Mechanisms of action and resistance].
    Taléns-Visconti R, Garrigues TM, Cantón E.
    Rev Esp Quimioter; 2002 Dec 15; 15(4):313-24. PubMed ID: 12587036
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of quinolone resistance in Salmonella.
    Cloeckaert A, Chaslus-Dancla E.
    Vet Res; 2001 Dec 15; 32(3-4):291-300. PubMed ID: 11432420
    [Abstract] [Full Text] [Related]

  • 14. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa.
    Kugelberg E, Löfmark S, Wretlind B, Andersson DI.
    J Antimicrob Chemother; 2005 Jan 15; 55(1):22-30. PubMed ID: 15574475
    [Abstract] [Full Text] [Related]

  • 15. Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates.
    Capilla S, Ruiz J, Goñi P, Castillo J, Rubio MC, Jiménez de Anta MT, Gómez-Lus R, Vila J.
    J Antimicrob Chemother; 2004 Jun 15; 53(6):1068-71. PubMed ID: 15117921
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai.
    Yang Y, Liao M, Gu WM, Bell K, Wu L, Eng NF, Zhang CG, Chen Y, Jolly AM, Dillon JA.
    J Antimicrob Chemother; 2006 Oct 15; 58(4):868-72. PubMed ID: 16880174
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of quinolone action and microbial response.
    Hawkey PM.
    J Antimicrob Chemother; 2003 May 15; 51 Suppl 1():29-35. PubMed ID: 12702701
    [Abstract] [Full Text] [Related]

  • 18. Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations.
    Avrain L, Garvey M, Mesaros N, Glupczynski Y, Mingeot-Leclercq MP, Piddock LJ, Tulkens PM, Vanhoof R, Van Bambeke F.
    J Antimicrob Chemother; 2007 Nov 15; 60(5):965-72. PubMed ID: 17693451
    [Abstract] [Full Text] [Related]

  • 19. Vibrio parahaemolyticus chromosomal qnr homologue VPA0095: demonstration by transformation with a mutated gene of its potential to reduce quinolone susceptibility in Escherichia coli.
    Saga T, Kaku M, Onodera Y, Yamachika S, Sato K, Takase H.
    Antimicrob Agents Chemother; 2005 May 15; 49(5):2144-5. PubMed ID: 15855551
    [No Abstract] [Full Text] [Related]

  • 20. Plasmid-mediated quinolone resistance.
    Martínez-Martínez L, Eliecer Cano M, Manuel Rodríguez-Martínez J, Calvo J, Pascual A.
    Expert Rev Anti Infect Ther; 2008 Oct 15; 6(5):685-711. PubMed ID: 18847406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.